Skip to content

Clinical trials

Recruiting Esophageal Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Status: Recruiting Country / region: Taiwan Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20201
20211
20233
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
National Taiwan University Hospital2
AbbVie1
AstraZeneca1
Chang Gung Memorial Hospital1
Daiichi Sankyo1
E-DA Hospital1
Seagen, a wholly owned subsidiary of Pfizer1
Taipei Veterans General Hospital, Taiwan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms12
Stomach Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Esophageal Squamous Cell Carcinoma3
Lung Neoplasms2
Ovarian Neoplasms2
Pancreatic Neoplasms2
Squamous Cell Carcinoma of Head and Neck2
Urinary Bladder Neoplasms2
Uterine Cervical Neoplasms2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.